The objective of this study was to assess the frequency of early deaths associated with birth asphyxia of very low birth weight infants between 2005 and 2010, in Brazil. This population study enrolled ...

The objective of this study was to determine the efficacy of mild hypothermia via selective head cooling as a neuroprotective therapy in term infants with perinatal asphyxia. s: Our results suggest ...

An updated Cochrane review found low or very low quality evidence. An updated Cochrane review found low or very low quality evidence regarding the use of prophylactic barbiturates in infants with ...

The risk of experiencing an oxygen deficit at birth (birth asphyxia) increases for babies born to women who are overweight or obese, according to a new study. The risk of experiencing an oxygen ...

Perinatal or neonatal asphyxia is a syndrome caused by decreased oxygenation of a foal's tissues during the birth process, writes Dr. Neil Williams in the January edition of Equine Disease Quarterly, ...

Cooling babies deprived of oxygen at birth (perinatal asphyxia) can reduce the number of children who develop epilepsy later in childhood, according to a new study. Cooling babies deprived of oxygen ...

(HealthDay News) — The benefits of moderate hypothermia following perinatal asphyxia can be seen in middle childhood, according to a study published in the July 10 issue of the New England Journal of ...

Women should be especially alert to any discomfort during pregnancy, Chinese Medical University Hospital department of neonatology doctor Tsai Ming-lun (蔡明倫) said, adding that they should go in for a ...

Birth asphyxia is a medical term that refers to a newborn baby suffering oxygen deprivation during birth that lasts for a sufficient period of time to cause significant damage – primarily to the ...

The BMJ is an international peer reviewed medical journal and a fully "online first" publication. Our publishing model–"continuous publication"– means that all articles appear on bmj.com before being ...

The health effects of fetal growth restriction (FGR) can last a lifetime, and the latest research from Hudson Institute is showing just how pervasive those effects can be on the cardiovascular system.